Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study

Liana G. Apostolova, Sona Babakchanian, Kristy S. Hwang, Amity E. Green, Dimitar Zlatev, Yi Yu Chou, Charlie Decarli, Clifford R Jr. Jack, Ronald Carl Petersen, Paul S. Aisen, Jeffrey L. Cummings, Arthur W. Toga, Paul M. Thompson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We analyzed the baseline and 3-year T1-weighted magnetic resonance imaging data of 110 amnestic mild cognitive impairment (MCI) participants with minimal hippocampal atrophy at baseline from the Alzheimer's Disease Cooperative Study group MCI Donepezil/Vitamin E trial. Forty-six subjects converted to Alzheimer disease (AD) (MCIc), whereas 64 remained stable (MCInc). We used the radial distance technique to examine the differences in lateral ventricle shape and size between MCIc and MCInc and the associations between ventricular enlargement and cognitive decline. MCIc group had significantly larger frontal and right body/occipital horns relative to MCInc at baseline and significantly larger bilateral frontal, body/occipital, and left temporal horns at follow-up. Global cognitive decline measured with AD Assessment scale cognitive subscale and Mini-Mental State Examination and decline in activities of daily living (ADL) were associated with posterior lateral ventricle enlargement. Decline in AD Assessment scale cognitive subscale and ADL were associated with left temporal and decline in Mini-Mental State Examination with right temporal horn enlargement. After correction for baseline hippocampal volume, decline in ADL showed a significant association with right frontal horn enlargement. Executive decline was associated with right frontal and left temporal horn enlargement.

Original languageEnglish (US)
Pages (from-to)174-181
Number of pages8
JournalAlzheimer Disease and Associated Disorders
Volume27
Issue number2
DOIs
StatePublished - Apr 2013

Fingerprint

Vitamins
Alzheimer Disease
Temporal Lobe
Activities of Daily Living
Lateral Ventricles
Horns
Vitamin E
Atrophy
Magnetic Resonance Imaging
Cognitive Dysfunction
donepezil

Keywords

  • AD
  • Alzheimer disease
  • brain atrophy
  • imaging
  • MCI
  • mild cognitive impairment
  • MRI
  • ventricular enlargement

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Gerontology
  • Clinical Psychology

Cite this

Apostolova, L. G., Babakchanian, S., Hwang, K. S., Green, A. E., Zlatev, D., Chou, Y. Y., ... Thompson, P. M. (2013). Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study. Alzheimer Disease and Associated Disorders, 27(2), 174-181. https://doi.org/10.1097/WAD.0b013e3182677b3d

Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study. / Apostolova, Liana G.; Babakchanian, Sona; Hwang, Kristy S.; Green, Amity E.; Zlatev, Dimitar; Chou, Yi Yu; Decarli, Charlie; Jack, Clifford R Jr.; Petersen, Ronald Carl; Aisen, Paul S.; Cummings, Jeffrey L.; Toga, Arthur W.; Thompson, Paul M.

In: Alzheimer Disease and Associated Disorders, Vol. 27, No. 2, 04.2013, p. 174-181.

Research output: Contribution to journalArticle

Apostolova, LG, Babakchanian, S, Hwang, KS, Green, AE, Zlatev, D, Chou, YY, Decarli, C, Jack, CRJ, Petersen, RC, Aisen, PS, Cummings, JL, Toga, AW & Thompson, PM 2013, 'Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study', Alzheimer Disease and Associated Disorders, vol. 27, no. 2, pp. 174-181. https://doi.org/10.1097/WAD.0b013e3182677b3d
Apostolova, Liana G. ; Babakchanian, Sona ; Hwang, Kristy S. ; Green, Amity E. ; Zlatev, Dimitar ; Chou, Yi Yu ; Decarli, Charlie ; Jack, Clifford R Jr. ; Petersen, Ronald Carl ; Aisen, Paul S. ; Cummings, Jeffrey L. ; Toga, Arthur W. ; Thompson, Paul M. / Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study. In: Alzheimer Disease and Associated Disorders. 2013 ; Vol. 27, No. 2. pp. 174-181.
@article{b472595964584d91adad7e0a9e42aed0,
title = "Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study",
abstract = "We analyzed the baseline and 3-year T1-weighted magnetic resonance imaging data of 110 amnestic mild cognitive impairment (MCI) participants with minimal hippocampal atrophy at baseline from the Alzheimer's Disease Cooperative Study group MCI Donepezil/Vitamin E trial. Forty-six subjects converted to Alzheimer disease (AD) (MCIc), whereas 64 remained stable (MCInc). We used the radial distance technique to examine the differences in lateral ventricle shape and size between MCIc and MCInc and the associations between ventricular enlargement and cognitive decline. MCIc group had significantly larger frontal and right body/occipital horns relative to MCInc at baseline and significantly larger bilateral frontal, body/occipital, and left temporal horns at follow-up. Global cognitive decline measured with AD Assessment scale cognitive subscale and Mini-Mental State Examination and decline in activities of daily living (ADL) were associated with posterior lateral ventricle enlargement. Decline in AD Assessment scale cognitive subscale and ADL were associated with left temporal and decline in Mini-Mental State Examination with right temporal horn enlargement. After correction for baseline hippocampal volume, decline in ADL showed a significant association with right frontal horn enlargement. Executive decline was associated with right frontal and left temporal horn enlargement.",
keywords = "AD, Alzheimer disease, brain atrophy, imaging, MCI, mild cognitive impairment, MRI, ventricular enlargement",
author = "Apostolova, {Liana G.} and Sona Babakchanian and Hwang, {Kristy S.} and Green, {Amity E.} and Dimitar Zlatev and Chou, {Yi Yu} and Charlie Decarli and Jack, {Clifford R Jr.} and Petersen, {Ronald Carl} and Aisen, {Paul S.} and Cummings, {Jeffrey L.} and Toga, {Arthur W.} and Thompson, {Paul M.}",
year = "2013",
month = "4",
doi = "10.1097/WAD.0b013e3182677b3d",
language = "English (US)",
volume = "27",
pages = "174--181",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study

AU - Apostolova, Liana G.

AU - Babakchanian, Sona

AU - Hwang, Kristy S.

AU - Green, Amity E.

AU - Zlatev, Dimitar

AU - Chou, Yi Yu

AU - Decarli, Charlie

AU - Jack, Clifford R Jr.

AU - Petersen, Ronald Carl

AU - Aisen, Paul S.

AU - Cummings, Jeffrey L.

AU - Toga, Arthur W.

AU - Thompson, Paul M.

PY - 2013/4

Y1 - 2013/4

N2 - We analyzed the baseline and 3-year T1-weighted magnetic resonance imaging data of 110 amnestic mild cognitive impairment (MCI) participants with minimal hippocampal atrophy at baseline from the Alzheimer's Disease Cooperative Study group MCI Donepezil/Vitamin E trial. Forty-six subjects converted to Alzheimer disease (AD) (MCIc), whereas 64 remained stable (MCInc). We used the radial distance technique to examine the differences in lateral ventricle shape and size between MCIc and MCInc and the associations between ventricular enlargement and cognitive decline. MCIc group had significantly larger frontal and right body/occipital horns relative to MCInc at baseline and significantly larger bilateral frontal, body/occipital, and left temporal horns at follow-up. Global cognitive decline measured with AD Assessment scale cognitive subscale and Mini-Mental State Examination and decline in activities of daily living (ADL) were associated with posterior lateral ventricle enlargement. Decline in AD Assessment scale cognitive subscale and ADL were associated with left temporal and decline in Mini-Mental State Examination with right temporal horn enlargement. After correction for baseline hippocampal volume, decline in ADL showed a significant association with right frontal horn enlargement. Executive decline was associated with right frontal and left temporal horn enlargement.

AB - We analyzed the baseline and 3-year T1-weighted magnetic resonance imaging data of 110 amnestic mild cognitive impairment (MCI) participants with minimal hippocampal atrophy at baseline from the Alzheimer's Disease Cooperative Study group MCI Donepezil/Vitamin E trial. Forty-six subjects converted to Alzheimer disease (AD) (MCIc), whereas 64 remained stable (MCInc). We used the radial distance technique to examine the differences in lateral ventricle shape and size between MCIc and MCInc and the associations between ventricular enlargement and cognitive decline. MCIc group had significantly larger frontal and right body/occipital horns relative to MCInc at baseline and significantly larger bilateral frontal, body/occipital, and left temporal horns at follow-up. Global cognitive decline measured with AD Assessment scale cognitive subscale and Mini-Mental State Examination and decline in activities of daily living (ADL) were associated with posterior lateral ventricle enlargement. Decline in AD Assessment scale cognitive subscale and ADL were associated with left temporal and decline in Mini-Mental State Examination with right temporal horn enlargement. After correction for baseline hippocampal volume, decline in ADL showed a significant association with right frontal horn enlargement. Executive decline was associated with right frontal and left temporal horn enlargement.

KW - AD

KW - Alzheimer disease

KW - brain atrophy

KW - imaging

KW - MCI

KW - mild cognitive impairment

KW - MRI

KW - ventricular enlargement

UR - http://www.scopus.com/inward/record.url?scp=84878850825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878850825&partnerID=8YFLogxK

U2 - 10.1097/WAD.0b013e3182677b3d

DO - 10.1097/WAD.0b013e3182677b3d

M3 - Article

C2 - 23694947

AN - SCOPUS:84878850825

VL - 27

SP - 174

EP - 181

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - 2

ER -